Company: SHPH
Filing Date: 2025-04-21
Form Type: 8-K
Source: 0001641172-25-005553
Chunk: 0

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-04-21
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item
8.01 Other Events.

On
April 21, 2025, Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (the “ Company”), issued a press release announcing
that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025,
at 2:30 p. m. Pacific Time (5:30 p. m. Eastern Time). Dr. Anatoly Dritschilo, M. D., our Chairman of the Board of Directors and Chief Scientific
Officer, will be hosting the presentation and answering questions at the conclusion.

Dr.
Dritschilo’s presentation will focus on providing an overview and update on the Company’s ongoing Phase 2 trial of Ropidoxuridine
and RT for treatment of patients with glioblastoma as well as advancements being made in the Company’s Shuttle Diagnostics subsidiary
which aims to develop pretreatment diagnostic blood tests and imaging agents for prostate cancer patients.

A
copy of the press release is attached hereto as Exhibit 99.1 and furnished herewith.

Forward-Looking
Statements

This
Current Report on Form 8-K contains “forward-looking statements” within the meaning of Section 21E of the Exchange Act and
the Private Securities Litigation Reform Act of 1995. Forward-looking statements may relate to statements concerning future results,
strategy and plans of the Company (including certain statements which may be identified by the use of the words “plans,”
“expects,” “does not expect,” “estimated,” “is expected,” “budget,” “scheduled,”
“estimates,” “forecasts,” “intends,” “anticipates,” “does not anticipate”
or “believes,” or variations of such words and phrases, or state that certain actions, events or results “may,”
“could,” “would,” “might,” “projects,” “will,” “will be taken,”
“occur” or “be achieved”). Forward-looking statements are based on the opinions and estimates of management of
the Company, as of the date such statements are made, and they are subject to known and unknown risks, uncertainties, assumptions and
other factors that may cause the actual results, performance or achievements to be materially different from those expressed or implied
by such forward-looking statements. Additional information on these and other factors that may cause actual results and the Company’s
performance to differ materially is included in the Company’s periodic